The study of 342 patients with schizophrenia showed significant effects of the adducin ADD2 polymorphisms, with CC genotype carriers performing better on almost all cognitive domains assessed by the Brief Assessment of Cognition in Schizophrenia (BACS).
The study, using the Italian version of the BACS and normative data, was conducted at the Universit a Vita-Salute San Raffaele, Milan, Italy and is published in the January issue of the European Journal of Medical Genetics.

Bosia, M., et al., ADDing a piece to the puzzle of cognition in schizophrenia, European Journal of Medical Genetics (2016)